Context Capital Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $367,000 distributed in 284 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Bannix Acquisition Corp. with a value of $48K, Inception Growth Acquisition LTD with a value of $37K, Denali Cap Acquisition Corp Wt with a value of $36K, Rf Acquisition Corp Rt with a value of $29K, and Global Blockchain Acq Corp Rt with a value of $28K.
Examining the 13F form we can see an increase of $37K in the current position value, from $330K to 367K .
Below you can find more details about Context Capital Management, LLC portfolio as well as his latest detailed transactions.
$130,000
$104,000
$1,000
$0
Stock Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q2 2023
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 19.5%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 30.0%
-
$0
0.0% of portfolio
-
Q2 2024
Added 14.42%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 38.99%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 30.4%
Centurion Acquisition Corp
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 6.2%
Cardio Diagnostics Holdgs In
-
$0
0.0% of portfolio
-
Q1 2023
New
Cantor Equity Partners Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
Cactus Acquisition Corp 1 Lt
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 8.11%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 39.03%
Collegium Pharmaceutical Inc
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 61.61%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 38.46%
-
$0
0.0% of portfolio
-
Q4 2022
New
$0
$0
0.0% of portfolio
14,168
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 99.98%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 99.97%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 99.9%
-
$0
0.0% of portfolio
-
Q3 2024
Added 4.16%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 99.9%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
New
Conduit Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2023
New
Bridger Aerospace Grp Hldgs
-
$0
0.0% of portfolio
-
Q1 2023
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 26.89%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 30.16%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 99.91%
-
$0
0.0% of portfolio
-
Q3 2024
Added 26.45%
-
$0
0.0% of portfolio
-
Q3 2024
Added 38.06%
-
$0
0.0% of portfolio
-
Q3 2024
New
Amphastar Pharmaceuticals In
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 5.18%
Alpha Star Acquisition Corp
-
$0
0.0% of portfolio
-
Q3 2024
New
Alchemy Invts Acquisitn Corp
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 53.33%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 9.96%
-
$0
0.0% of portfolio
-
Q3 2024
New
